Oric Pharmaceuticals Stock

oricpharma.comHealthcareFounded: 2014Funding to Date: $173MM

ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.

Register for Details

For more details on financing and valuation for Oric Pharmaceuticals, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Oric Pharmaceuticals.

Register Today

Team

Management Team

Jacob Chacko MD
Chief Executive Officer & Board Member
Charles Sawyers MD
Co-Founder
Dominic Piscitelli
Chief Financial Officer
Matthew Panuwat
Chief Business Officer
Lori Friedman Ph.D
Chief Scientific Officer
Richard Heyman Ph.D
Co-Founder, Chairman & Board Member
Scott Lowe Ph.D
Co-Founder

Board Members

Leo Guthart
Laurence Lasky Ph.D
Richard Scheller Ph.D
Carl Gordon Ph.D
OrbiMed
Richard Heyman Ph.D
Peter Svennilson
The Column Group
Jacob Chacko MD

Other companies like Oric Pharmaceuticals in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$885.01MM
Sector
 
 

News

ORIC Pharmaceuticals followed in the footsteps of the other biotechs that have managed to go public this month, selling more shares than it expected for a
/PRNewswire/ -- ORIC Pharmaceuticals, a privately held, clinical-stage oncology company focused on developing cancer treatments that address mechanisms of...